Evans syndrome: a report on 12 patients

Area of Science:

• Hematology
• Immunology
• Autoimmune Diseases

Background:

• Evans syndrome is a rare autoimmune disorder characterized by concurrent or sequential autoimmune hemolytic anemia and immune thrombocytopenia.
• The condition presents diagnostic and therapeutic challenges due to its complex autoimmune mechanisms.

Purpose of the Study:

• To analyze the clinical characteristics, treatment modalities, and outcomes of Evans syndrome patients.
• To identify prognostic factors associated with mortality in Evans syndrome.

Main Methods:

• Retrospective case series of 12 patients diagnosed with Evans syndrome between 1981 and 1989.
• Data collection included patient demographics, diagnostic criteria (direct antiglobulin test positive hemolytic anemia and immune thrombocytopenia), treatment interventions, serological markers, and patient outcomes.

Main Results:

• The mean age of presentation was 24.8 years, with a notable female predominance.
• All patients received high-dose steroids; additional treatments included IV immunoglobulin and methylprednisolone.
• Mortality occurred in 4 patients due to intracranial hemorrhage or pulmonary embolism.
• Six patients tested positive for antinuclear factor and anti-dsDNA antibodies, with 4 of these patients dying, suggesting a poorer prognosis.

Conclusions:

• Evans syndrome predominantly affects young females and requires prompt management with corticosteroids.
• The presence of antinuclear antibodies and anti-dsDNA antibodies is associated with increased mortality.
• Patients surviving the acute phase of Evans syndrome generally experience a reasonable long-term prognosis.